Latest filing published 04 Nov 2026 for MustGrow Biologics Corp..
Insider track record
No signal scores available.
Kevin Ross Helash: trading record in brief
Kevin Ross Helash discloses dealings in MustGrow Biologics Corp. to SEDI. We count 2 filings; the first trade dates from 1 November 2026 and the latest from 2 November 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 4 November 2026 came the latest disclosure, an option exercise in MustGrow Biologics Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kevin Ross Helash
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250,000 sharesOptionsTSXSEDI:4798061
- OptionsTSXSEDI:4798054
2 of 2 declarations